HighTower Advisors LLC decreased its stake in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 12.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 26,529 shares of the company’s stock after selling 3,750 shares during the period. HighTower Advisors LLC’s holdings in BlackRock Health Sciences Trust were worth $1,006,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently made changes to their positions in BME. Janney Montgomery Scott LLC raised its holdings in BlackRock Health Sciences Trust by 40.5% during the 4th quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after purchasing an additional 9,455 shares during the last quarter. Hara Capital LLC acquired a new position in BlackRock Health Sciences Trust in the fourth quarter valued at $832,000. Wolverine Asset Management LLC boosted its position in BlackRock Health Sciences Trust by 29.1% during the fourth quarter. Wolverine Asset Management LLC now owns 110,493 shares of the company’s stock valued at $4,191,000 after acquiring an additional 24,928 shares during the last quarter. AlphaStar Capital Management LLC acquired a new stake in BlackRock Health Sciences Trust during the 4th quarter worth about $878,000. Finally, Raymond James Financial Inc. bought a new position in shares of BlackRock Health Sciences Trust in the 4th quarter worth about $3,250,000.
BlackRock Health Sciences Trust Stock Performance
Shares of BlackRock Health Sciences Trust stock opened at $38.67 on Thursday. The stock’s 50-day moving average is $39.90 and its 200 day moving average is $40.03. BlackRock Health Sciences Trust has a one year low of $36.87 and a one year high of $42.64.
BlackRock Health Sciences Trust Announces Dividend
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Read More
- Five stocks we like better than BlackRock Health Sciences Trust
- Airline Stocks – Top Airline Stocks to Buy Now
- Energy Transfer: Powering Data With Dividends and Diversification
- How to Invest in Blue Chip Stocks
- Qualcomm Stock Is Coiling for a Breakout
- What is Insider Trading? What You Can Learn from Insider Trading
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.